These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 12960141

  • 1. Epigallocatechin-3-gallate inhibits activation of HER-2/neu and downstream signaling pathways in human head and neck and breast carcinoma cells.
    Masuda M, Suzui M, Lim JT, Weinstein IB.
    Clin Cancer Res; 2003 Aug 15; 9(9):3486-91. PubMed ID: 12960141
    [Abstract] [Full Text] [Related]

  • 2. Effects of epigallocatechin-3-gallate on growth, epidermal growth factor receptor signaling pathways, gene expression, and chemosensitivity in human head and neck squamous cell carcinoma cell lines.
    Masuda M, Suzui M, Weinstein IB.
    Clin Cancer Res; 2001 Dec 15; 7(12):4220-9. PubMed ID: 11751523
    [Abstract] [Full Text] [Related]

  • 3. Tea polyphenol (-)-epigallocatechin 3-gallate suppresses heregulin-beta1-induced fatty acid synthase expression in human breast cancer cells by inhibiting phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase cascade signaling.
    Pan MH, Lin CC, Lin JK, Chen WJ.
    J Agric Food Chem; 2007 Jun 27; 55(13):5030-7. PubMed ID: 17539658
    [Abstract] [Full Text] [Related]

  • 4. Epigallocatechin-3 gallate induces growth inhibition and apoptosis in human breast cancer cells through survivin suppression.
    Tang Y, Zhao DY, Elliott S, Zhao W, Curiel TJ, Beckman BS, Burow ME.
    Int J Oncol; 2007 Oct 27; 31(4):705-11. PubMed ID: 17786300
    [Abstract] [Full Text] [Related]

  • 5. EGCG inhibits activation of HER3 and expression of cyclooxygenase-2 in human colon cancer cells.
    Shimizu M, Deguchi A, Joe AK, Mckoy JF, Moriwaki H, Weinstein IB.
    J Exp Ther Oncol; 2005 Oct 27; 5(1):69-78. PubMed ID: 16416603
    [Abstract] [Full Text] [Related]

  • 6. EGCG down-regulates telomerase in human breast carcinoma MCF-7 cells, leading to suppression of cell viability and induction of apoptosis.
    Mittal A, Pate MS, Wylie RC, Tollefsbol TO, Katiyar SK.
    Int J Oncol; 2004 Mar 27; 24(3):703-10. PubMed ID: 14767556
    [Abstract] [Full Text] [Related]

  • 7. Green tea polyphenol epigallocatechin-3 gallate inhibits Her-2/neu signaling, proliferation, and transformed phenotype of breast cancer cells.
    Pianetti S, Guo S, Kavanagh KT, Sonenshein GE.
    Cancer Res; 2002 Feb 01; 62(3):652-5. PubMed ID: 11830514
    [Abstract] [Full Text] [Related]

  • 8. Mechanism of action of (-)-epigallocatechin-3-gallate: auto-oxidation-dependent inactivation of epidermal growth factor receptor and direct effects on growth inhibition in human esophageal cancer KYSE 150 cells.
    Hou Z, Sang S, You H, Lee MJ, Hong J, Chin KV, Yang CS.
    Cancer Res; 2005 Sep 01; 65(17):8049-56. PubMed ID: 16140980
    [Abstract] [Full Text] [Related]

  • 9. Epigallocatechin-3-gallate decreases VEGF production in head and neck and breast carcinoma cells by inhibiting EGFR-related pathways of signal transduction.
    Masuda M, Suzui M, Lim JT, Deguchi A, Soh JW, Weinstein IB.
    J Exp Ther Oncol; 2002 Sep 01; 2(6):350-9. PubMed ID: 12440226
    [Abstract] [Full Text] [Related]

  • 10. Microarray-assisted pathway analysis identifies mitogen-activated protein kinase signaling as a mediator of resistance to the green tea polyphenol epigallocatechin 3-gallate in her-2/neu-overexpressing breast cancer cells.
    Guo S, Lu J, Subramanian A, Sonenshein GE.
    Cancer Res; 2006 May 15; 66(10):5322-9. PubMed ID: 16707458
    [Abstract] [Full Text] [Related]

  • 11. Constitutive activation of signal transducers and activators of transcription 3 correlates with cyclin D1 overexpression and may provide a novel prognostic marker in head and neck squamous cell carcinoma.
    Masuda M, Suzui M, Yasumatu R, Nakashima T, Kuratomi Y, Azuma K, Tomita K, Komiyama S, Weinstein IB.
    Cancer Res; 2002 Jun 15; 62(12):3351-5. PubMed ID: 12067972
    [Abstract] [Full Text] [Related]

  • 12. EGCG inhibits activation of the insulin-like growth factor-1 receptor in human colon cancer cells.
    Shimizu M, Deguchi A, Hara Y, Moriwaki H, Weinstein IB.
    Biochem Biophys Res Commun; 2005 Sep 02; 334(3):947-53. PubMed ID: 16053920
    [Abstract] [Full Text] [Related]

  • 13. Anticancer effects of (-)-epigallocatechin-3-gallate on ovarian carcinoma cell lines.
    Huh SW, Bae SM, Kim YW, Lee JM, Namkoong SE, Lee IP, Kim SH, Kim CK, Ahn WS.
    Gynecol Oncol; 2004 Sep 02; 94(3):760-8. PubMed ID: 15350370
    [Abstract] [Full Text] [Related]

  • 14. The phyto-chemical (-)-epigallocatechin gallate suppresses gene expression of epidermal growth factor receptor in rat hepatic stellate cells in vitro by reducing the activity of Egr-1.
    Fu Y, Chen A.
    Biochem Pharmacol; 2006 Jul 14; 72(2):227-38. PubMed ID: 16750517
    [Abstract] [Full Text] [Related]

  • 15. (-)-Epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells.
    Shimizu M, Deguchi A, Lim JT, Moriwaki H, Kopelovich L, Weinstein IB.
    Clin Cancer Res; 2005 Apr 01; 11(7):2735-46. PubMed ID: 15814656
    [Abstract] [Full Text] [Related]

  • 16. (-)-Epigallocatechin-3-gallate down-regulates EGFR, MMP-2, MMP-9 and EMMPRIN and inhibits the invasion of MCF-7 tamoxifen-resistant cells.
    Farabegoli F, Papi A, Orlandi M.
    Biosci Rep; 2011 Apr 01; 31(2):99-108. PubMed ID: 20446926
    [Abstract] [Full Text] [Related]

  • 17. The effect of green tea extract and EGCG on the signaling network in squamous cell carcinoma.
    Liu X, Zhang DY, Zhang W, Zhao X, Yuan C, Ye F.
    Nutr Cancer; 2011 Apr 01; 63(3):466-75. PubMed ID: 21391127
    [Abstract] [Full Text] [Related]

  • 18. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA, Mehmi I, Atlas E, Colomer R, Lupu R.
    Int J Oncol; 2004 Mar 01; 24(3):591-608. PubMed ID: 14767544
    [Abstract] [Full Text] [Related]

  • 19. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.
    Thangapazham RL, Singh AK, Sharma A, Warren J, Gaddipati JP, Maheshwari RK.
    Cancer Lett; 2007 Jan 08; 245(1-2):232-41. PubMed ID: 16519995
    [Abstract] [Full Text] [Related]

  • 20. The green tea compound, (-)-epigallocatechin-3-gallate downregulates N-cadherin and suppresses migration of bladder carcinoma cells.
    Rieger-Christ KM, Hanley R, Lodowsky C, Bernier T, Vemulapalli P, Roth M, Kim J, Yee AS, Le SM, Marie PJ, Libertino JA, Summerhayes IC.
    J Cell Biochem; 2007 Oct 01; 102(2):377-88. PubMed ID: 17348027
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.